{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:14:20Z","timestamp":1770344060535,"version":"3.49.0"},"reference-count":32,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5551\/jat.26385","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T23:19:30Z","timestamp":1411514370000},"page":"257-264","source":"Crossref","is-referenced-by-count":13,"title":["The Serum YKL-40 Level is Associated with Vascular Injury and Predicts Proteinuria in Nephrotic Syndrome Patients"],"prefix":"10.5551","volume":"22","author":[{"given":"Ismail","family":"Kocyigit","sequence":"first","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozkan","family":"Gungor","sequence":"additional","affiliation":[{"name":"Kahramanmaras State Hospital, Nephrology Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ender","family":"Dogan","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serhat","family":"Karadavut","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem","family":"Karakukcu","sequence":"additional","affiliation":[{"name":"Kayseri Education and Research Hospital, Biochemistry Laboratory"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eray","family":"Eroglu","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozcan","family":"Orscelik","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydin","family":"Unal","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Dogan","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat Hayri","family":"Sipahioglu","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Tokgoz","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oktay","family":"Oymak","sequence":"additional","affiliation":[{"name":"Erciyes University Medical Faculty, Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nandi M, Mondal R: Nephrotic syndrome with atherosclerosis. Indian Pediatr, 2011; 48: 907-908","DOI":"10.1007\/s13312-011-0131-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gungor O, Demirci MS, Kircelli F, Tatar E, Sipahi S, Hur E, Sen S, Toz H, Basci A, Ok E: Increased arterial stiffness in patientswith nephrotic syndrome.Clin Nephrol, 2013; 79: 1-6","DOI":"10.5414\/CN107760"},{"key":"3","unstructured":"3) Caraba A, Romo\u015fan I: Endothelial dysfunction in the nephrotic syndrome. Med Pregl, 2007; 60: 66-69"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wiwanitkit V: YKL-40 as new cardiac biomarker. Anadolu Kardiyol Derg, 2014; 14: 98-99","DOI":"10.5152\/akd.2013.5209"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Okyay GU, Er RE, Tekbudak MY, Pa\u015fao\u011flu \u00d6, Inal S, \u00d6ne\u00e7 K, Pa\u015fao\u011flu H, Altok K, Derici \u00dc, Erten Y: Novel inflammatory marker in dialysis patients: YKL-40. Ther-Apher Dial, 2013; 17: 193-201","DOI":"10.1111\/j.1744-9987.2012.01141.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ye HM, Lu YZ, Liang XM, Lin YZ, Li Y, Zhang ZY, Tzeng CM: Clinicalsignificance of combinedtesting of YKL-40 with CEA in Chinese colo rectal cancer patients. ClinLab, 2014; 60: 397-405","DOI":"10.7754\/Clin.Lab.2013.121027"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wang Y, Ripa RS, Johansen JS, Gabrielsen A, Steinbruchel DA, Friis T, Bindslev L, Haack-S\u00f8rensen M, J\u00f8rgensen E, Kastrup J: YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J, 2008; 42: 295-302","DOI":"10.1080\/14017430802220567"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tao H, Yang JJ, Shi KH, Huang C, Zhang L, Lv XW, Li J: The significance of YKL-40 protein in liver fibrosis. Inflamm Res, 2014; 63: 249-254","DOI":"10.1007\/s00011-013-0698-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Specjalski K, Jassem E: YKL-40 protein is a marker of asthma. J Asthma, 2011; 48: 767-772","DOI":"10.3109\/02770903.2011.611955"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Erzin Y, Uzun H, Karatas A, Celik AF: Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn\u2019s disease. J Gastroenterol Hepatol, 2008; 23: 357-362","DOI":"10.1111\/j.1440-1746.2007.05121.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sakamoto F, Katakami N, Kaneto H, Yasuda T, Takahara M, Miyashita K, Kuroda A, Matsuhisa M, Kosugi K, Shimomura I: Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus. Endocr J, 2013; 60: 73-79","DOI":"10.1507\/endocrj.EJ12-0238"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yasuda T, Kaneto H, Katakami N, Kuroda A, Matsuoka TA, Yamasaki Y, Matsuhisa M, Shimomura I: YKL-40, a newbiomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract, 2011; 91: 50-52","DOI":"10.1016\/j.diabres.2010.11.015"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tatar E, Gungor O, Celtik A, Sisman AR, Yaprak M, Asci G, Ozkahya M, Toz H : Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients. Ann Transplant, 2013; 18: 95-100","DOI":"10.12659\/AOT.883844"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE: Impaired endothe-lialfunction occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol, 1993; 22: 854-858","DOI":"10.1016\/0735-1097(93)90203-D"},{"key":"15","unstructured":"15) Hooman N, Isa-Tafreshi R, Otukesh H, Mostafavi SH, Hallaji F: Carotid artery function in children with idiopathic nephrotic syndrome. Nefrologia, 2013; 33: 650-656"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rahul I, Krishnamurthy S, Satheesh S, Biswal N, Bobby Z, Lakshminarayanan S: Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectionalcase-controls tudy. Clin Exp Nephrol, 2014 Mar 18","DOI":"10.1007\/s10157-014-0958-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sharma B, Saha A, Dubey NK, Kapoor K, Anubhuti, Batra VV, Upadhayay AD: Endothelial dysfuntion in children with idiopathic nephrotic syndrome. Atherosclerosis, 2014; 233: 704-706","DOI":"10.1016\/j.atherosclerosis.2014.01.055"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Soyoral YU, Aslan M, Emre H, Begenik H, Erdur FM, Turkel A, Selek S, Erkoc R: Serum paraoxonase activity and oxidative stress in patientswith adult nephrotic syndrome. Atherosclerosis, 2011; 218: 243-246","DOI":"10.1016\/j.atherosclerosis.2011.05.037"},{"key":"19","unstructured":"19) Diao YY, L\u00fc QZ, Yang CS, Wei D: Association between serum YKL-40 levels and endothelial function in hypertensive patients. Zhonghua Xin Xue GuanBing Za Zhi, 2013; 4: 121-125"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ma WH, Wang XL, Du YM, Wang YB, Zhang Y, Wei DE, Guo LL, Bu PL: Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovasc Disord, 2012; 29: 12-35","DOI":"10.1186\/1471-2261-12-35"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Turkyilmaz AK, Devrimsel G, Kirbas A, Cicek Y, Karkucak M, Capkin E, Gokmen F: Relationship between pulse wave velocityand serum YKL-40level in patients with early rheumatoid arthritis. Rheumatol Int, 2013; 33: 2751-2756","DOI":"10.1007\/s00296-013-2810-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Rathcke CN, Vestergaard H: YKL-40--an emerging biomarker in cardio vascular disease and diabetes. Cardiovasc Diabetol, 2009; 8: 61","DOI":"10.1186\/1475-2840-8-61"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kastrup J: Can YKL-40 be a new inflammatory biomarker in cardio vascular disease? Immunobiology, 2012; 217: 483-491","DOI":"10.1016\/j.imbio.2011.04.007"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Mathiasen AB, Henningsen KM, Harutyunyan MJ, Mygind ND, Kastrup J: YKL-40: a newbiomarker in cardiovascular disease? Biomark Med, 2010; 4: 591-600","DOI":"10.2217\/bmm.10.58"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Shao R: YKL-40 acts as an angiogenicfactor to promotetum or angiogenesis. Front Physiol, 2013; 4: 122","DOI":"10.3389\/fphys.2013.00122"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-S\u00f8rensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B: Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis, 2010; 211: 589-595","DOI":"10.1016\/j.atherosclerosis.2010.02.035"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kastrup J, Johansen JS, Winkel P, Hansen JF, Hildebrandt P, Jensen GB, Jespersen CM, Kj\u00f8ller E, Kolmos HJ, Lind I, Nielsen H, Gluud C; CLARICOR Trial Group: High serum YKL-40concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.EurHeart J, 2009; 30: 1066-1072","DOI":"10.1093\/eurheartj\/ehp049"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tan J, Jaung R, Gamble G, Cundy T: Proteinuric renal disease in type 2 diabetes-is remissionof proteinuria associated with improved mortality and morbidity? Diabetes Res Clin Pract, 2014; 103: 63-70","DOI":"10.1016\/j.diabres.2013.11.023"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC: Effect of proteinuria on mortality in NIDDM. Diabetes, 1988; 37: 1499-1504","DOI":"10.2337\/diab.37.11.1499"},{"key":"30","unstructured":"30) Currie G, Delles C: Proteinuria and its relation to cardiovascular disease.Int J Nephrol Renovasc Dis, 201; 7: 13-24"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Joles JA, Stroes ES, Rabelink TJ: Endothelialfunction in proteinuric renal disease. Kidney Int Suppl, 1999; 71: 57-61","DOI":"10.1046\/j.1523-1755.1999.07115.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Schalkwijk CG, Stehouwer CD: Vascular complications in diabetes mellitus: the role of endothelial dysfunction. ClinSci (Lond), 2005; 109: 143-159","DOI":"10.1042\/CS20050025"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T17:39:32Z","timestamp":1650217172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/22\/3\/22_26385\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.26385","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}